Twenty years’ experience with the Swiss data registry for assisted reproductive medicine: outcomes, key trends and recommendations for improved practice - Concepedia

Concepedia

Publication | Open Access

Twenty years’ experience with the Swiss data registry for assisted reproductive medicine: outcomes, key trends and recommendations for improved practice

DOI Full Paper Access

46

Citations

22

References

2015

Year

Geyter De, Peter Fehr, Rebecca Moffat, Isabel M. L. Gruber, Wolff von

Swiss Medical Weekly

Abstract

Optimal ovarian stimulation should be designed for the retrieval of 10 to 15 oocytes per treatment. Swiss legislation should enable and stimulate a policy of elective single embryo transfer to avoid multiple births.

References

	Year	Citations
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles Sesh Kamal Sunkara, V. Rittenberg, Nick Raine‐Fenning, Human Reproduction	2011	913
Elective Single-Embryo Transfer versus Double-Embryo Transfer in in Vitro Fertilization Ann Thurin, Jon Hausken, Torbjörn Hillensjø, New England Journal of Medicine	2004	592
Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology Antonio La Marca, Simone Giulini, Alessandra Tirelli, Human Reproduction	2006	328
Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Tsung‐Hsien Lee, C.-H. Liu, C.-C. Huang, Human Reproduction	2007	278
Elective single day 3 embryo transfer halves the twinning rate without decrease in the ongoing pregnancy rate of an IVF/ICSI programme J. Gerris Human Reproduction	2002	195
Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study Georg Griesinger, Laura Schultz, Thomas Bauer, Fertility and Sterility FertilityReproductive HealthGynecologyFemale Reproductive SystemFinal Oocyte Maturation	2011	184
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients Joan-Carles Arce, Antonio La Marca, Bjarke M. Klein, Fertility and Sterility	2013	176
Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability Oybek Rustamov, Alwyn Smith, S. A. Roberts, Human Reproduction	2012	162
Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF Allen P. Yates, Oybek Rustamov, S. A. Roberts, Human Reproduction	2011	150
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle‐stimulating hormone starting dose in <i>in vitro</i> fertilisation cycles Antonio La Marca, Enrico Papaleo, Valentina Grisendi, BJOG An International Journal of Obstetrics & Gynaecology	2012	146

Page 1